Sernova Corp.
TSX:SVA.TOBiotechnology
-$0.01 today
- Market cap
- $50.98M
- Beta
- 0.66
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$0.03
Volume 0.55M
Average 0.12M
SVA.TO Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Sernova Corp.TSX: SVA.TO
Other Non-current Liabilities · Q2 FY2026 · quarter ended Apr 2026
Other non-current liabilities remains negative
Q2 FY2026 other non-current liabilities was CA$0, compared with CA$0 a year earlier.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Other non-current liabilities increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
CAD · from the balance sheet
- Latest · FY2025
- 0 CAD
- Year-over-year change
- —
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-31 | 0 | — |
| FY2024 | 2024-10-31 | 0 | — |
| FY2023 | 2023-10-31 | 0 | — |
| FY2022 | 2022-10-31 | 0 | — |
| FY2021 | 2021-10-31 | 0 | — |
Other Non-current Liabilities vs competitors
How SVA.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Other non-current liabilities amounts to 0.0% of total assets for SVA.TO, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Apr 2026 | $71.85K USD | -90.2% | -77.9% | 0.3% | |
| Apr 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding SVA.TO) | — | -90.2% | -77.9% | 0.3% | |
Competitors are the stored peer set for SVA.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Oct 2021 | FY2022 Oct 2022 | FY2023 Oct 2023 | FY2024 Oct 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 27.87M | 3.78M | 8.72M | 6.01M | 265K |
| Short-term Investments | 0 | 46M | 11.08M | 0 | 0 |
| Net Receivables | 448.95K | 1.15M | 1.05M | 298.1K | 122.63K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 159.17K | 135.01K |
| Total Current Assets | 28.33M | 51.09M | 21.02M | 6.47M | 522.65K |
| Property, Plant & Equipment (Net) | 176.33K | 653.7K | 507.44K | 833.93K | 17.72K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 716.79K | 516.75K | 316.72K | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 599.89K | 223.86K | 259.16K | 223.86K | 223.86K |
| Total Non-current Assets | 1.49M | 1.39M | 1.08M | 1.06M | 241.58K |
| Total Assets | 29.82M | 52.48M | 22.11M | 7.53M | 764.23K |
| Account Payables | 379.52K | 3.61M | 6.85M | 17.24M | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 16.24M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 287.77K | 4.6M | 757.27K | 19.91M | 8.56M |
| Total Current Liabilities | 1.48M | 4.74M | 9.59M | 20.02M | 24.8M |
| Long-term Debt | 0 | 0 | 0 | 0 | 1.04M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 275.98K | 136.12K | 0 | 468.48K | 1.04M |
| Total Liabilities | 1.75M | 4.88M | 9.59M | 20.48M | 25.84M |
| Common Stock | 74.01M | 110.99M | 110.99M | 116.68M | 118.7M |
| Retained Earnings | (54.75M) | (79.17M) | (118.17M) | (150.36M) | (166.1M) |
| Accumulated OCI | 3.69M | 3.3M | 0 | 0 | 537.14K |
| Other Stockholders Equity | 0 | 0 | 0 | 35.07K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 28.07M | 47.61M | 12.51M | (12.96M) | (25.08M) |
| Total Debt | 393.35K | 275.98K | 136.12K | 569.94K | 17.28M |
| Net Debt | (27.48M) | (3.5M) | (8.59M) | (5.44M) | 17.02M |
Sernova Corp.
TSX:SVA.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.